Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders

被引：8

作者：

Bagnasco, Diego ^{[1
,2
]}

Nicola, Stefania ^{[3
]}

Testino, Elisa ^{[1
,2
]}

Brussino, Luisa ^{[3
]}

Pini, Laura ^{[4
]}

Caminati, Marco ^{[5
]}

Piccardo, Federica ^{[2
]}

Canevari, Rikki Frank ^{[6
]}

Melissari, Laura ^{[1
,2
]}

Ioppi, Alessandro ^{[6
]}

Guastini, Luca ^{[6
]}

Lombardi, Carlo ^{[7
]}

Milanese, Manlio ^{[8
]}

Losa, Francesca ^{[9
]}

Robbiano, Michela ^{[1
,2
]}

De Ferrari, Laura ^{[1
,2
]}

Riccio, Anna Maria ^{[1
,2
]}

Guida, Giuseppe ^{[10
]}

Bonavia, Marco ^{[11
]}

Fini, Donatella ^{[12
]}

Balbi, Francesco ^{[13
]}

Caruso, Cristiano ^{[14
]}

Paggiaro, Pierluigi ^{[15
]}

Blasi, Francesco ^{[16
,17
,18
]}

Heffler, Enrico ^{[19
,20
]}

Paoletti, Giovanni ^{[19
,20
]}

Canonica, Giorgio Walter ^{[19
,20
]}

Senna, Gianenrico ^{[5
]}

Passalacqua, Giovanni ^{[1
,2
]}

机构：

[1] Univ Genoa, IRCCS Policlin San Martino, Allergy & Resp Dis, I-16132 Genoa, Italy

[2] Univ Genoa, Dept Internal Med DIMI, I-16132 Genoa, Italy

[3] AO Ordine Mauriziano Torino, SCDU Immunol & Allergol, Cso Re Umberto 109, I-10128 Turin, Italy

[4] Spedali Civili Brescia, Resp Med Unit, Piazzale Spedali Civili 1, I-25123 Brescia, Italy

[5] Univ Verona, Dept Med, I-37134 Verona, Italy

[6] Univ Genoa, ENT Dept, IRCCS Policlin San Martino, I-16132 Genoa, Italy

[7] Fdn Poliambulanza, Dept Unit Allergol Immunol & Pulm Dis, I-25124 Brescia, Italy

[8] ASL2, S Corona Hosp, Dept Resp Dis, I-17027 Pietra Ligure, Italy

[9] ASST Mantova, UO Allergol & Clin Immunol, I-46100 Mantua, Italy

[10] Univ Torino, Dept Clin & Biol Sci, Orbassano 10043, Italy

[11] ASL3, Hosp Ge Arenzano, Dept Rehabil Pulmonol, I-16149 Genoa, Italy

[12] Hosp Sarzana SP, Dept Pneumol, I-19125 La Spezia, Italy

[13] Hosp Imperia, Dept Pneumol, I-18100 Imperia, Italy

[14] Univ Cattolica Sacro Cuore, Dept Med & Surg Sci, Fdn Universitary Policlin A Gemelli IRCCS, I-20123 Rome, Italy

[15] Univ Pisa, Dept Surg Med & Mol Pathol & Crit Care, I-56126 Pisa, Italy

[16] Univ Milan, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy

[17] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Resp Unit, I-20122 Milan, Italy

[18] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Adult Cyst Fibrosis Ctr, Internal Med Dept, I-20122 Milan, Italy

[19] IRCCS Human Clin & Res Hosp, Unit Personalized Med Asthma & Allergy, I-20089 Rozzano, Italy

[20] Humanitas Univ, Dept Biomed Sci, I-20072 Pieve Emanuele, Italy

来源：

BIOMEDICINES | 2023年 / 11卷 / 09期

关键词：

severe asthma; eosinophils; mepolizumab; CRSwNP; IL-5; real life; registry; SEVERE EOSINOPHILIC ASTHMA; MULTICENTER;

D O I：

10.3390/biomedicines11092424

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The efficacy mepolizumab in severe asthmatic patients is proven in the literature. Primarily to study the effect of mepolizumab on exacerbations, steroid dependence, and the continuation of efficacy in the long term. Secondarily to evaluate the effect of the drug on nasal polyps. Analyzing data from SANI (Severe Asthma Network Italy) clinics, we observed severe asthmatic patients treated with mepolizumab 100 mg/4 weeks, for a period of 3 years. 157 patients were observed. Exacerbations were reduced from the first year (-84.6%) and progressively to 90 and 95% in the second and third ones. Steroid-dependent patients decreased from 54% to 21% and subsequently to 11% in the second year and 6% in the third year. Patients with concomitant nasal polyps, assessed by SNOT-22, showed a 49% reduction in value from baseline to the third year. The study demonstrated the long-term efficacy of mepolizumab in a real-life setting.

引用

页数：10

共 50 条

[41] Long-Term Efficacy, Safety and Drug Survival of Ustekinumab in a Spanish Cohort of Patients with Moderate to Severe Plaque Psoriasis
Puig, Lluis
Ruiz-Salas, Veronica
DERMATOLOGY, 2015, 230 (01) : 46 - 54
[42] Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients
Valverde-Monge, Marcela
Sanchez-Carrasco, Patricia
Betancor, Diana
Barroso, Blanca
Rodrigo-Munoz, Jose Manuel
Mahillo-Fernandez, Ignacio
Arismendi, Ebymar
Bobolea, Irina
Cardaba, Blanca
Cruz, Maria Jesus
Del Pozo, Victoria
Dominguez-Ortega, Javier
Gonzalez-Barcala, Francisco Javier
Olaguibel, Jose Maria
Luna-Porta, Juan Alberto
Martinez-Rivera, Carlos
Mullol, Joaquim
Munoz, Xavier
Peleteiro-Pedraza, Lorena
Valles, Cesar Picado
Plaza, Vicente
Quirce, Santiago
Rial, Manuel Jorge
Soto-Retes, Lorena
Valero, Antonio
Sastre, Joaquin
ARCHIVOS DE BRONCONEUMOLOGIA, 2024, 60 (01): : 23 - 32
[43] Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study
Vultaggio, Alessandra
Aliani, Maria
Altieri, Elena
Bracciale, Pietro
Brussino, Luisa
Caiaffa, Maria Filomena
Cameli, Paolo
Canonica, Giorgio Walter
Caruso, Cristiano
Centanni, Stefano
D'Amato, Maria
De Michele, Fausto
Del Giacco, Stefano
Di Marco, Fabiano
Menzella, Francesco
Pelaia, Girolamo
Rogliani, Paola
Romagnoli, Micaela
Schino, Pietro
Senna, Gianenrico
Benci, Marco
Boarino, Silvia
Schroeder, Jan Walter
RESPIRATORY RESEARCH, 2023, 24 (01)
[44] Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study
Alessandra Vultaggio
Maria Aliani
Elena Altieri
Pietro Bracciale
Luisa Brussino
Maria Filomena Caiaffa
Paolo Cameli
Giorgio Walter Canonica
Cristiano Caruso
Stefano Centanni
Maria D’Amato
Fausto De Michele
Stefano Del Giacco
Fabiano Di Marco
Francesco Menzella
Girolamo Pelaia
Paola Rogliani
Micaela Romagnoli
Pietro Schino
Gianenrico Senna
Marco Benci
Silvia Boarino
Jan Walter Schroeder
Respiratory Research, 24
[45] Long-term clinical and economic outcomes in previously untreated paediatric patients with severe haemophilia A: A nationwide real-world study with 700 person-years
Vepsalainen, K.
Riikonen, P.
Lassila, R.
Arola, M.
Huttunen, P.
Lahteenmaki, P.
Mottonen, M.
Selander, T.
Martikainen, J.
HAEMOPHILIA, 2018, 24 (03) : 436 - 444
[46] Bimekizumab efficacy and safety through 3 years in patients with moderate-to-severe plaque psoriasis: long-term results from the BE RADIANT phase IIIb trial open-label extension period
Warren, Richard B.
Lebwohl, Mark
Thaci, Diamant
Gooderham, Melinda
Pinter, Andreas
Paul, Carle
Gisondi, Paolo
Szilagyi, Balint
White, Katy
Deherder, Delphine
Staelens, Fabienne
Lambert, Jeremy
Strober, Bruce
BRITISH JOURNAL OF DERMATOLOGY, 2025,
[47] Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis For Up to 3 Years An Open-Label Extension of Randomized Clinical Trials
Armstrong, April W.
Lebwohl, Mark
Warren, Richard B.
Sofen, Howard
Imafuku, Shinichi
Ohtsuki, Mamitaro
Spelman, Lynda
Passeron, Thierry
Papp, Kim A.
Kisa, Renata M.
Vaile, John
Berger, Victoria
Vritzali, Eleni
Hoyt, Kim
Colombo, Matthew J.
Scotto, Julie
Banerjee, Subhashis
Strober, Bruce
Thaci, Diamant
Blauvelt, Andrew
JAMA DERMATOLOGY, 2025, 161 (01) : 56 - 66
[48] Omalizumab Treatment for Atopic Severe Persistant Asthma: A Single-Center, Long-Term, Real-Life Experience with 38 Patients
Turk, Murat
Bahcecioglu, Sakine Nazik
Tutar, Nuri
Oymak, Fatma Sema
Gulmez, Inci
Yilmaz, Insu
TURKISH THORACIC JOURNAL, 2018, 19 (04) : 187 - 192
[49] Long-Term Efficacy and Safety of Guselkumab for Moderate to Severe Psoriasis: A 3-Year Real-Life Retrospective Study
Megna, Matteo
Potestio, Luca
Fabbrocini, Gabriella
Ruggiero, Angelo
PSORIASIS-TARGETS AND THERAPY, 2022, 12 : 205 - 212
[50] Comparison of long-term outcome between patients aged < 65 years vs. ≥65 years after atrial fibrillation ablation
Kis, Zsuzsanna
Noten, Anna M. E.
Martirosyan, Mihran
Hendriks, Astrid A.
Bhagwandien, Rohit
Szili-Torok, Tamas
JOURNAL OF GERIATRIC CARDIOLOGY, 2017, 14 (09) : 569 - 574

← 1 2 3 4 5 →